Literature DB >> 3101368

Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.

S Sukenik, A el-Roeiy, Y Shoenfeld.   

Abstract

The lupus anticoagulant (LA) is an acquired autoantibody of the IgG or IgM type that acts on platelet factor III, inhibiting the generation of the prothrombin activator complex. It is prevalent in 5-10% of SLE cases and, in contradistinction to the name anticoagulant, it may be associated with thrombotic events, recurrent abortion or intrauterine death. Anti-cardiolipin antibody like LA, is an anti-phospholipid antibody and also causes recurrent thrombotic events. Mention has been made of a possible cross-reactivity between anti-phospholipid antibodies and anti-DNA antibodies. The optimal treatment for this problem is at present unknown.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3101368     DOI: 10.1159/000206027

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  1 in total

1.  Serious complications following treatment of chronic idiopathic thrombocytopenic purpura.

Authors:  W Wanachiwanawin; S Visudhiphan; A Piankijagum; S Vatanavicharn
Journal:  Postgrad Med J       Date:  1988-06       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.